-
The Lancet published a China study that will rapidly impact stroke treatment worldwide
Time of Update: 2022-11-05
*For medical professionals onlyCombined with various previous studies, it is clear that it is not advisable to strengthen the antihypertensive scheme. Written by | Ling Jun ON OCTOBER 28, THE LANCET,
-
Professor Su Chunxia: The pattern is open, and the brain protector is strong - Bugtinib has created a new idea of ALK brain metastasis treatment
Time of Update: 2022-09-07
prefaceBrain metastases have long been the "nightmare" of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). Studies have shown that patients with ALK-positive
-
A total of 246,594,191 confirmed cases of new crowns worldwide
Time of Update: 2021-11-11
According to the latest data from the WHO website, as of 17:04 on the 1st Central European Time (0:04 on the 2nd Beijing Time), the number of confirmed cases worldwide increased by 296,434 from the previous day, reaching 246,594,191; the number of deaths increased by 4,671.
-
The whitest paint in the world is included in the Guinness Book of World Records
Time of Update: 2021-09-28
As early as the 1970s, some researchers made some attempts to invent a very white paint, believing that this method can also cool the house, which would be a more environmentally friendly method than using air conditioners .
-
Xi'an Yangsen IL-12 and IL-23 inhibitors Starno ® (Usnu mono-anti-injection) are available in China
Time of Update: 2020-06-09
Recently, johnson and company (http:// in China Pharmaceutical (http:// subsidiary Xi'an Yangsen Pharmaceutical Co., Ltd announced that its all-human source "double-target" leukocyte interleuk
-
Knowledge of painting | how about the price of Asian lacquer
Time of Update: 2020-04-03
Core tip: Asiatic paint is the world's leading provider of comprehensive coating solutions Since it was put into production in China in 1998, Asiatic paint China has been firmly based on the coating i
-
Zhongsheng pharmaceutical T790M new lung cancer drug approved clinical
Time of Update: 2017-12-27
Source: on December 25, 2017, Zhongsheng pharmaceutical announced that zsp0391, a new non-small cell lung cancer class 1 drug jointly developed with Wuxi apptec, obtained the clinical approval issued
